Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05462821 · ClinicalTrials.gov registry record · Phase 3
Full-Time Occlusion Therapy for Intermittent Exotropia in Children
A Phase 3 study, sponsored by Jaeb Center for Health Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 73
- Enrollment target
NCT05462821 is a Phase 3 study that has completed, run by Jaeb Center for Health Research. The registered enrollment target is 73 participants.
The verdict
NCT05462821, a Phase 3 study, has completed, sponsored by Jaeb Center for Health Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 73 participants
- Enrollment target
Study Summary
Determine whether full-time patching is more effective than observation for improving distance control of IXT after 3 months of treatment (on-treatment outcome).
Interventions
- DEVICE Eye Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2025-05-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05462821
The ClinicalTrials.gov registry entry for NCT05462821 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Eye Patch is the first listed.
NCT05462821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05462821 about?
NCT05462821 is a clinical study titled "Full-Time Occlusion Therapy for Intermittent Exotropia in Children". Determine whether full-time patching is more effective than observation for improving distance control of IXT after 3 months of treatment (on-treatment outcome).
What is the current status of trial NCT05462821?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 73 participants. The study started on 2022-11-01. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT05462821?
The interventions under investigation include: Eye Patch (DEVICE).
Who is sponsoring clinical trial NCT05462821?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.